Inosine Pranobex

异丙肌苷

Report date: 2022/12/07 17:07:48
NME

Base Information

Drug NameInosine Pranobex
Drug Alias NameInosiplexIsoprinosineImunovirNPT-10381NP-113
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Nucleoside analogues
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsVirus DiseasesRespiratory Tract Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Inactive CompaniesCairo University
Active IndicationsVirus Diseases
Inactive IndicationsRespiratory Tract Infections

Other Information

ATC CodeJ05AX05